Low-dose methotrexate was not clinically effective for lowering blood pressure among patients without rheumatic disease who have cardiovascular risk factors.

Methotrexate sodium 2.5mg ... Increased risk of hepatotoxicity with alcoholism or receiving total cumulative dose (≥1.5g). Update immunizations according to current guidelines prior to initiation.

Patients treated with both TNF blockers and methotrexate had a lower response to the vaccine than those treated with anti-TNF agents alone, and patients receiving methotrexate alone had the lowest ...

The most common side effect is mild elevations of liver transaminases. Patients receiving methotrexate should stop prenatal vitamins or folic acid supplements. During treatment with methotrexate ...

In addition, reductions in erythrocyte sedimentation rate and C-reactive protein level were seen only patients receiving methotrexate. Importantly, the rate of adverse events was significantly ...

All subjects received treatment with the combination of ENBREL and methotrexate. Subjects receiving methotrexate monotherapy during the 3-year double-blind TEMPO trial were switched to the ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

A single infusion of infliximab 1 mg/kg had activity, but less than in patients receiving 10 mg/kg ... of infliximab with and without concomitant methotrexate therapy in patients with RA.